FDA 483 - Celgene International Sarl - June 16, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
During an inspection, Celgene International Sarl in Boudry, Switzerland, was cited for inadequate cleaning and sanitization of equipment. Specifically, a parts washing station used for drug product containers was found to have components, such as O-rings and flanges, that were not adequately cleaned, posing a risk of cross-contamination and microbial growth to drug products. This observation highlights a significant concern regarding the firm's adherence to cGMP for equipment maintenance and sanitation.
ID · 7e41c20e-1772-4268-9eb2-be6641b756b4